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cules. A prominent member of the PR-10 family, the major birch pollen allergen Bet v 1, is the main cause of spring pollinosis
in the temperate climate zone of the northern hemisphere. Bet v 1 binds various ligand molecules to its internal cavity, and immu-
nologic effects of the presence of ligand have been discussed. However, the mechanism of binding has remained elusive. In this
study, we show that in solution Bet v 1.0101 is conformationally heterogeneous and cannot be represented by a single structure.
NMR relaxation data suggest that structural dynamics are fundamental for ligand access to the protein interior. Complex forma-
tion then leads to significant rigidification of the protein along with a compaction of its 3D structure. The data presented herein
provide a structural basis for understanding the immunogenic and allergenic potential of ligand binding to Bet v 1 allergens.INTRODUCTIONThe major birch pollen allergen Bet v 1 is a member of the
ubiquitous family of pathogenesis-related plant proteins
of class-10 (PR-10) (1). PR-10 proteins are known to be
involved in defense mechanisms of plants in response to
various pathogens, low temperature, oxidative stress, or
UV radiation (2–4). PR-10 proteins consist of ~160 amino
acids that fold into a highly conserved seven-stranded,
highly curved, antiparallel b-sheet (b1–b7) along with two
consecutive short a-helices (a1 and a2) and a long C-termi-
nal helix (a3; Fig. 1) (1).
Together, these structural elements form an extended
internal cavity that is capable of binding a variety of physi-
ologically relevant amphipathic ligand molecules (1,5–8).
It is believed that the biological function of PR-10 proteins
involves the storage and transport of phytohormones and
other small-molecule ligands.
As a prominent member of the PR-10 protein family, the
major birch pollen allergen Bet v 1 has been subjected to a
detailed immunological characterization (see www.allergen.
org). Bet v 1 is a highly immunogenic protein that represents
the main cause of allergic sensitization against birch pollen
(9,10). More than 13 different isoforms of Bet v 1 have been
identified, sharing more than 95% sequence identity (11,12)
yet different immunogenic properties, with strikingly
different IgE binding capacities in some cases (11). In addi-
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0006-3495/14/12/2972/10 $2.00forms of Bet v 1, including the isoform Bet v 1.0101 (Bet
v 1a) both with and without ligand(s) bound (8), the sin-
gle-site mutants M139L (13) and F30V (8) of Bet v
1.0101, the low IgE binding isoform Bet v 1.0106 (Bet v
1j) (8), the naturally occurring hypoallergenic isoform Bet
v 1.0107 (Bet v 1l) (5), and Bet v 1.0112 (i.e., the Bet v
1a variant F62L) (14) along with a low IgE binding sin-
gle-site (E45S) mutant of Bet v 1.0112 (15). Structural
data for Bet v 1.0112 are also available for the complex of
this protein with a monoclonal murine IgG antibody (16).
The accumulated data for Bet v 1 isoforms and mutants
(as well as other members of the PR-10 family) (17) display
little variation of the 3D protein structure, with almost iden-
tical protein scaffolds (the pairwise root mean-square devi-
ations (RMSDs) between these structures are below ~1 A˚;
see Table S1 in the Supporting Material). Notably, even
the binding of one or more ligand molecules, such as deox-
ycholate (DXC), naringenin, and kinetin, to Bet v 1 appears
to be accompanied by only minor structural adaptions, pre-
dominantly at the protein-ligand interaction surface inside
the binding cavity (8). However, ligand binding does have
an effect on the immunogenic and allergenic properties of
Bet v 1. It was recently shown that binding of DXC to Bet
v 1.0101 leads to an increase of the thermodynamic stability
of this protein, increases resistance to proteolysis, and af-
fects the binding of human IgE by stabilizing the conforma-
tional epitopes on the protein surface (18).
As an additional aspect, from the structural data that are
available in the literature to date, it is not evident how
exactly ligand molecules enter into the cavity. Three open-
ings to the interior cavity have been identified in crystallo-
graphic studies of Bet v 1 proteins (1,8). These relativelyhttp://dx.doi.org/10.1016/j.bpj.2014.10.062
FIGURE 1 Complex structure of Bet v 1.0101 with two SDS molecules. (A) Overview of Bet v 1.0101 in complex with the outer (front, left) and inner
(right) SDS molecules shown in yellow stick representation. Three putative entrances (ε1–ε3) to the inner hydrophobic cavity are indicated with arrows. (B)
Zoom-in view of the outer SDS binding site. The ligand molecule in yellow sticks is superimposed on the experimental 2Fo-Fc electron density contoured at
0.8 s. Protein residues that are involved in important interactions with SDS are labeled. (C) Zoom-in view of the inner SDS binding site. The ligand molecule
in yellow sticks is superimposed on the experimental 2Fo-Fc electron density contoured at 0.8 s. Protein residues that are involved in important interactions
with SDS are labeled. To see this figure in color, go online.
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ements and might function as gates for solvent water and
small ligands (8). It is clear, however, that a certain level
of structural dynamics is required for ligand entry, in partic-
ular for voluminous molecules such as naringenin, kinetin,
and the recently described natural ligand quercetin-3-O-
sophoroside (7).
To better elucidate these biophysical features of Bet v 1, a
detailed characterization of its structural dynamics is
crucial. Here, we characterize the hydrodynamic and dy-
namic properties of the major Bet v 1 isoform Bet v
1.0101, which constitutes ~35% of the total protein mass
in birch pollen (11), by combining NMR spectroscopic ex-
periments with molecular dynamics (MD) simulations, crys-
tallography, and functional assays. Our hydrodynamic NMR
experiments indicate that ligand binding to the interior cav-
ity of Bet v 1.0101 leads to a small but measurable average
compaction of the 3D protein structure. The data further
show that the conformational space that is dynamically
sampled by Bet v 1.0101 when it is bound to ligand mole-
cules is notably different from that sampled by the apo pro-
tein. Evidently, compaction of the Bet v 1 structure upon
ligand binding is accompanied by a significant rigidification
of the protein backbone and the formation of a less dynamic
protein. The accumulated data show that these observations
are related to the mechanism by which this protein captures
and binds ligand molecules. We hypothesize that the rigid-
ification and compaction of Bet v 1 upon ligand binding is
related to the observed differences in the proteolytic
behavior and IgE binding capacities of the ligand-free and
ligand-bound forms of this protein (18).MATERIALS AND METHODS
NMR sample preparation
Wild-type Bet v 1.0101 protein was prepared as previously described
(8,19). Uniformly 15N- (or 15N, 13C)-labeled Bet v 1.0101 protein was iso-lated and purified from Escherichia coli strain BL21(De3) Star cultures
grown in minimal M9 medium enriched with 15NH4Cl (and
13C-glucose).
The protein was purified as described elsewhere (19) with some minor
changes to the protocol. As a final purification step, size-exclusion chroma-
tography was performed using a 16/60 Superdex75 prep grade column (GE
Healthcare Life Sciences, Uppsala, Sweden) with a running buffer of 5 mM
sodium phosphate pH 8.0. The concentrations of the protein solutions were
determined using NanoPhotometer Pearl (ε0 (Bet v 1.0101) ¼ 10,430
M1cm1).NMR experiments
NMR spectra were recorded at a temperature of 298 K on Agilent Direct-
Drive 500 and Varian Inova 800 MHz spectrometers. All spectrometers
were equipped with room-temperature probe heads. Data were processed
using NMRpipe (20) and analyzed using the program CcpNmr (21).Tri-
ple-resonance experiments and all relaxation experiments were per-
formed on samples containing 0.4 mM Bet v 1.0101 in 5 mM sodium
phosphate pH 8.0 buffer and 8% 2H2O. All other NMR experiments
were performed using 0.2 mM Bet v 1.0101 samples. Experiments with
ligands were performed using samples at concentration ratios of Bet v
1.0101/ligand ¼ 1:2 (8-anilino-1-naphthalenesulfonic acid (ANS)), 1:3
(sodium dodecyl sulfate (SDS)), and 1:3 (sodium tetradecyl sulfate
(STS)), respectively.
Chemical shift assignments (1H, 15N, 13C’, 13Ca, and 13Cb) were obtained
using the standard 3D triple-resonance experiments HNCACB, HNCO,
CBCA(CO)NH, and HNCA. The resonance assignments have been depos-
ited in the Biological Magnetic Resonance Data Bank (http://www.bmrb.
wisc.edu) under accession number 25272. To analyze chemical shifts and
determine TALOSþ secondary structure probabilities, the program
TALOSþ (22) was utilized. Cumulative chemical shift differences, Ducum,












where N is the number of nuclei for which chemical shifts are available (%
5), Dui is the shift difference of nucleus i between ligand-bound and ligand-
free states, and ui,std is a nucleus-specific normalization factor that takes
into account the possible range of chemical shifts (i.e., 1 standard deviation
(SD), as observed in the Biological Magnetic Resonance Data Bank).
For pulsed-field-gradient NMR experiments to measure protein trans-
lational diffusion, we employed stimulated-echo LED experiments asBiophysical Journal 107(12) 2972–2981
2974 Grutsch et al.previously described by Choy et al. (24), with gradient field strengths
ranging from 22 to 58 G/cm. For each 2D spectrum, complex data matrices
composed of 1024  86 points with a maximum acquisition time of 48 ms
in the 15N dimension were recorded. A total of 32 scans per free induction
decay (FID) were obtained with a recycle delay of 1.6 s. The data were apo-
dized using shifted sine bell functions in both dimensions and zero-filled
to 512 and 2048 data points. For each spectrum, the intensities (partial
peak volumes) of the peaks were obtained by summation in boxes of 5 
5 data points centered on the peak maximum. The decay of the protein
NMR resonances with increasing gradient strength was analyzed as
described previously (24) to yield diffusion attenuation rates on a per-res-
idue basis. The average and SD of the attenuation rates of the 20 best-fit
residues (as judged by the RMSD) were determined. To estimate the hy-
drodynamic radii, we performed stimulated-echo LED using dioxane as a
standard reference under identical buffer conditions and assumed a hydro-
dynamic radius of 2.12 A˚ for dioxane (25). As a control experiment for the
negligibility of ligand viscosity, we used 1 mM of the 15N-KIX domain of
CREB protein in 50 mM potassium phosphate (pH 5.5) and 25 mM NaCl
containing 8% 2H2O and added the same excess of ligand as for the
Bet v 1 samples.
Heteronuclear 1H, 15N NOE, rotating-frame longitudinal relaxation rates
R1r, and longitudinal relaxation rates R1 were measured for Bet v 1.0101 in
the states Bet v 1.0101 (free) and Bet v 1.0101 (SDS-bound) at 298 K and
800 MHz 1H Larmor frequency, as previously described (26). The hetero-
nuclear 1H, 15N NOE was obtained by recording, in an interleaved manner,
one spectrum with a delay of 3 s followed by proton saturation for 4 s and
another spectrum with a delay of 7 s without proton saturation. Relaxation
delays between 10.9 and 870.4 ms were used for R1 experiments, and delays
between 10.0 and 100.0 ms were used for the R1r measurements. For each
2D spectrum, complex data matrices composed of 1639  90 points with a
maximum acquisition time of 31.2 ms in the 15N dimension were recorded.
Eight scans per FID were obtained with a recycle delay of 1.8 s (R1)/1.5 s
(R1r). The data were apodized using shifted sine bell functions in both di-
mensions and zero-filled to 512 and 2048 data points. For each spectrum,
the intensities (partial peak volumes) of the peaks were obtained by summa-
tion in boxes of 5  5 data points centered on the peak maximum. The data
were fitted to exponential decays to determine R1r and R1, and R2 values
were derived from the data as previously described (26). Internal dynamics,
along with the rotational correlation time, were analyzed with the program
FAST-ModelFree (27). The isotropic rotational correlation time, tc, was
determined as 8.4 ns and 8.7 ns for SDS-bound Bet v 1.0101 and free
Bet v 1.0101, respectively.
15N relaxation dispersion experiments were performed at two static
magnetic field strengths corresponding to 1H Larmor frequencies of 500
MHz and 800 MHz, using Carr-Purcell-Meiboom-Gill (CPMG) pulse se-
quences described previously (28–30). Spectra were collected as series
of 2D data sets with CPMG field strengths, nCPMG ¼ 1/(2TCPMG), where
TCPMG is the time between two successive 180
 pulses in the CPMG pulse
train, between 33 Hz and 933 Hz (with repeat experiments at 67 Hz and
600 Hz), with a relaxation delay set to 30 ms. Spectra were recorded as
1366  90 complex points with a maximum acquisition time of 50 ms
in the 15N dimension. The t1 (t2) domain data were apodized using shifted
sine bell functions in both dimensions and zero-filled to 512 (2048) data
points. Partial peak volumes were obtained by adding the intensities in
5  5 grids centered on the peak maximum, and converted to effective
relaxation rates via R2,eff ¼ 1/Trelax  ln(I/I0), where I is the partial
peak volume at a given CPMG field strength and I0 is the partial peak vol-
ume in a reference experiment recorded without Trelax. The relaxation
dispersion data were analyzed by globally fitting the Carver-Richards
equation (31) to the experimental data using in-house-written software
to extract Dudisp values.
Titration experiments with SDS, STS, and ANS as ligands were per-
formed by stepwise addition of the ligands (each dissolved in 5 mM sodium
phosphate pH 8.0 and 8% 2H2O) to a 450 ml sample of
15N-labeled Bet v
1.0101 to a ratio of 1:2 (ANS) and 1:3 (SDS and STS). Heteronuclear singleBiophysical Journal 107(12) 2972–2981quantum coherence (HSQC) titration experiments were recorded at 500
MHz. A series of identical 1H–15N HSQC spectra were performed as com-
plex data matrices composed of 1026  80 points, with maximum acquisi-
tion times of 128 and 44.4 ms in the 1H and 15N dimensions, respectively.
Sixteen scans per FID were obtained with a recycle delay of 1.4 s, resulting
in a total experimental time of ~1 h for each 1H-15N HSQC spectrum. For
each spectrum, the intensities (partial peak volumes) of the peaks were ob-
tained by summation in boxes of 5  5 data points centered at the peak
maximum. Chemical shift perturbations (CSPs) caused by the binding of
the ligand were plotted against the increasing ligand concentration. Exper-
imental data were fitted to extract the dissociation constant Kd.MD simulations
MD simulations were performed to probe the conformational dynamics of
Bet v 1.0101 in the apo and ligand-bound states at atomic resolution. For
this purpose, DXC was chosen as ligand because it leaves the interior cavity
during the time course of the simulation. We used high-resolution x-ray
structures of Bet v 1.0101 in the presence and absence of two molecules
of DXC as starting points (Protein Data Bank (PDB) ID: 4A80 and 4A88
(8)). The systems were protonated for physiological pH using the tool pro-
tonate3d of MOE (32) and soaked in a truncated octahedral box of TIP3P
water molecules (33) with a minimum wall distance of 10 A˚. The bound
ligand DXC was parameterized using the Generalized Amber Force Field
(GAFF) (34). Partial charges were derived from RESP fitting (35) at HF-
6/31G*-level using Gaussian03 (36). The applied GAFF parameters for
DXC are available from the authors on request. Simulations were per-
formed within the AMBER package using GPU-accelerated PMEMD
(37) and the AMBER force field ff99SBildn (38). Thus, we were able to
sample a 1 ms unrestrained MD trajectory in the NpTensemble for both sys-
tems after employing a careful equilibration protocol involving several
minimization, heating, and cooling steps (39). Simulations were performed
at 300 K.
To broaden the phase-space coverage, we performed a replica exchange
MD (REMD) simulation (40) of apo Bet v 1.0101 employing the same pa-
rameters described above. We ran 32 parallel replica simulations in 2 K
temperature spacing spanning a range from 300 to 362 K. The replica
were allowed to exchange with a probability of 0.25 while attempting
1000 exchanges over the sampling time of 100 ns. Analyses are presented
for the simulation at 300 K only. MD trajectories were analyzed using ptraj
and cpptraj of AmberTools (41). After performing standard stability tests
via RMSD plots, we analyzed the radius of gyration using all protein atoms
as well as B-factors of 13Ca atoms after global alignment to the structure
after equilibration.Protein crystallization and structure
determination
To grow Bet v 1.0101 crystals using the vapor diffusion technique, 5 mg/ml
protein (1 ml) was mixed with a precipitation solution consisting of 2.5 M
(NH4)2SO4 and 1.5% 2-methyl-2,4-pentanediol. Crystals were obtained by
equilibrating the drops against the 100 ml reservoir consisting of the precip-
itant solution. SDS was added at a 2 mM concentration to the already grown
apo crystals for soaking.
Crystals were flash frozen in a nitrogen stream at 100 K, and diffrac-
tion data were collected at the ESRF beamline ID14-4. Diffraction data
were processed by using the CCP4 software suite (42), solved by Molec-
ular Replacement (43), and refined using REFMAC (44). Due to a severe
ice ring at 1.9 A˚, x-ray diffraction data were used at 2 A˚ resolution for
refinement. Electron density interpretation and model building were car-
ried out using the program Coot (45). Data collection and refinement
statistics are summarized in Table S2. The coordinates of Bet v 1.0101
bound to SDS have been deposited in the Protein Data Bank under entry
code 4QIP.
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NMR diffusion experiments
We employed pulsed-field-gradient (PFG) translational
diffusion NMR methods to probe the hydrodynamic radius
of Bet v 1.0101 without and with ligand bound. As model
ligands, we chose SDS, STS, and ANS. SDS and STS
both bind to Bet v 1.0101 in a 1:2 stoichiometry (6), with
affinities between 1 mM (STS)/7 mM (SDS) and 20 mM
(STS)/100 mM (SDS) (Figs. S1 and S2) (6), whereas ANS
binds to Bet v 1.0101 in a 1:1 stoichiometry, with ~19 mM
affinity at neutral pH (6). Fig. 2 shows the PFG translational
diffusion data for apo Bet v 1.0101 and for Bet v 1.0101 af-
ter addition of SDS, STS, or ANS to the protein.
It is evident from this experiment that ligand binding to
Bet v 1.0101 has a measurable effect on its translational
diffusion behavior. In all three cases (SDS, STS, and
ANS), ligand binding accelerates diffusion by roughly 4%.
Detergents such as SDS and STS are known to moderately
increase the solvent viscosity at mM concentrations. How-
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FIGURE 2 Compactness of Bet v 1.0101. Top: PFG-NMR translational
diffusion data. Relative translational diffusion coefficients (Dt/Dt,apo) of
Bet v 1.0101 (0.2 mM) without ligand (three repeat experiments), and
with ligand bound (0.6 mM SDS or STS, 0.4 mM ANS) are shown.
Mean values (bars) and SDs (error bars) for 20 backbone amide NH reso-
nances are reported. Control experiments were performed with the CBP
KIX domain. Bottom: distribution of the radius of gyration of apo Bet v
1.0101 (red) and DXC-bound Bet v 1.0101 (green) found in MD simula-
tions. To see this figure in color, go online.(concentration of ligand <1 mM, 298 K) the effect of these
ligands on solvent viscosity was negligible (Fig. 2), as
shown by control experiments with the CBP KIX domain,
which does not bind to SDS, STS, or ANS (see Materials
and Methods).
The translational diffusion constant, Dt, is related to the
hydrodynamic radius, rh, of a protein by the Stokes-Einstein
equation as Dt¼ kBT/6rhrh, where kB is the Boltzmann con-
stant, T is the temperature, and h is the solvent viscosity.
Thus, for Bet v 1.0101, the observed acceleration of transla-
tional diffusion upon ligand binding can clearly be ascribed
to a reduction of the hydrodynamic radius of the protein by
z4%, indicating a compaction of its 3D structure. In abso-
lute numbers, using dioxane as a reference substance for the
PFG-NMR diffusion measurements, this means that the hy-
drodynamic radius of Bet v 1.0101 decreases from ~20.1 A˚
to ~19.3 A˚ upon ligand binding. The hydrodynamic NMR
studies show that ligand binding to the major birch pollen
allergen Bet v 1.0101 is accompanied by a measurable de-
gree of compaction of the average protein structure.MD simulations
To verify the translational diffusion data, we performed MD
simulations of Bet v 1.0101 without ligand bound and in
complex with two molecules of DXC (8). The results indi-
cate that ligand binding has an effect on the conformational
space that is sampled by the Bet v 1 protein, as is evident
from the distributions of the radii of gyration of the con-
formers present in the simulations (Fig. 2). Specifically, in
the apo Bet v 1.0101 REMD simulations (40), a small pro-
portion of protein structures have a higher radius of gyration
(up to 16.3 A˚) compared with the DXC-bound protein.
Therefore, the MD data suggest that more expanded con-
formers are present in apo Bet v 1.0101, in line with the
translational diffusion NMR data. For crystalline Bet v 1,
x-ray crystallographic studies so far have indicated that
the 3D structure of Bet v 1 proteins in the crystalline state
is not affected appreciably by ligand binding (8). Indeed,
the radii of gyration of crystal structures that are available
in the PDB are all very similar, i.e., between 15.2 and
15.7 A˚ (Table S1). A solution NMR structural bundle of
Bet v 1.0101 in the absence of ligand was reported by Gaj-
hede et al. (14), with a strikingly similar radii of gyration
ranging between 15.3 and 15.7 A˚.
To calibrate the observed SDS-induced compaction of
Bet v 1 with previously reported structural data, we deter-
mined the crystal structure of the Bet v 1 with SDS. Consis-
tent with previous reports (6), we find two SDS molecules
bound to Bet v 1, which retains a conserved structure as
compared with complexes with other ligands or the apo
structure of Bet v 1 (8). The inner SDS binding site is
harbored by the prominent hydrophobic pocket and the
outer SDS binding site is located near entrance ε1, delimi-
tated by the C-terminal helix a3, as well as the loopsBiophysical Journal 107(12) 2972–2981
2976 Grutsch et al.connecting helix a2 with strand b2 and strands b3-b4
(Fig. 1). The outer SDS is extended and oriented approxi-
mately parallel to helix a3. The inner SDS molecule is simi-
larly extended and oriented approximately perpendicular to
the b-sheet, with its sulfate group pointing toward the cavity
entrance ε3. Both SDS molecules are defined by a diffuse
electron density, reflecting the inherent flexibility of the
alkane chain and at the same time indicating a preferred
binding mode for both SDS molecules. The inner sulfate in-
teracts with the hydroxyl group of Tyr-81 and the carbox-
ylate of Asp-69, whereas the sulfate of the outer SDS is
exposed to the solvent. The crystal structure, therefore, al-
lows us to unambiguously assign the inner SDS with a
high-affinity binding site (Kd ¼ 7 mM) and the outer SDS
with a lower-affinity binding site (Kd ¼ 100 mM; cf. Figs.
S1 and S2).
To probe for structural changes of Bet v 1.0101 in
response to ligand binding in solution, we analyzed the
NMR chemical shifts of the protein backbone. Chemical
shifts are sensitive reporters of the secondary structure of
proteins and thus provide probes of structural differences
between apo Bet v 1.0101 and complexes (46). A compari-
son of the chemical shifts of apo Bet v 1.0101 with com-
plex(es) of this protein can therefore provide information
about structural changes that accompany ligand binding.
Using triple-resonance experiments, we assigned the back-
bone 1HN, 15N and 13C nuclei of Bet v 1.0101 without ligand
present and in the presence of saturating amounts of SDS
and STS. We did not include ANS-bound Bet v 1.0101 in
the chemical shift analysis to avoid the effects on protein
chemical shifts that result from the aromatic moiety of ANS.
Fig. 3 compares the secondary structures of apo Bet v
1.0101 and Bet v 1.0101 in complex with SDS and STS
that were derived from the backbone chemical shifts usingBiophysical Journal 107(12) 2972–2981the program TALOSþ (22). As expected, the secondary
structures closely match the available crystal and NMR
structures (8,14). Notably, there are no appreciable differ-
ences between the TALOSþ of the apo protein Bet v
1.0101 and complexes of this protein with SDS or STS, con-
firming that the secondary structures of apo Bet v 1.0101
and complexes with SDS or STS are very similar. Fig. 3
also shows the cumulative change in backbone 1HN, 15N,
13C0, 13Ca, and 13Cb chemical shifts, Ducum, upon binding
to SDS and STS, respectively (23). For regions of the pro-
tein with little conformational difference between apo and
SDS or STS ligand-bound forms, Ducum values close to
zero are expected, whereas Ducum values exceeding ~1
ppm indicate a structural rearrangement upon ligand bind-
ing. For Bet v 1.0101, only minor chemical shift differences
between the apo and ligand-bound forms are found, with
Ducum well below 1 ppm, indicating that ligand binding
has only a small effect on the 3D structure of the protein.
Somewhat elevated Ducum values (>0.25 ppm) for SDS
and STS binding are found for residues in the central b-sheet
(Glu-73, Tyr-81, and Ile-102) and the C-terminal helix a3
(Ser-136). The backbone amide of residue Glu-73 (b4)
hydrogen bonds to residue 82 of strand b5, which is located
between two tyrosine residues, Tyr-81 and Tyr-83. The side
chains of both Tyr-81 and Tyr-83 are oriented to the inside
of the binding cavity, where they interact with bound ligand
(Fig. 1), consistent with previously reported crystallo-
graphic studies (5,8). Likewise, the aliphatic side chain of
Ile-102 (strand b6) points to the interior of the protein cav-
ity, where it interacts with ligands (6,8), and the backbone
carbonyl of Ile-102 is hydrogen bonded to the backbone
amide of Tyr-81. Ser-136 is located in a segment of helix
a3 (between 129 and 132) that is known to adapt its confor-
mation upon ligand binding to Bet v 1.0101 (8). These dataFIGURE 3 NMR chemical shift data. Top: sec-
ondary structure of Bet v 1.0101 as defined by Gaj-
hede et al. (14). Middle: TALOSþ secondary
structure probabilities (blue, b-sheet; red, a-helix)
of Bet v 1.0101 derived from 1HN, 15N, 13C’, 13Ca,
and 13Cb chemical shifts for the apo protein
compared with complexes with SDS and STS.
For residues that are marked by an asterisk, reso-
nance assignments were not obtained. Bottom:
cumulative chemical shift differences, Ducum, be-
tween Bet v 1.0101 in the absence of ligand and
Bet v 1.0101 in complex with SDS (blue) and
STS (red), respectively, as a function of residue
number. To see this figure in color, go online.
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graphic mapping of the inner SDS binding site that partially
overlaps with the binding site of ANS, DXC, naringenin,
kinetin, and other ligands to Bet v 1.0101.
Taken together, the accumulated chemical shift and hy-
drodynamic NMR data imply that ligand binding to Bet v
1.0101 is accompanied by a slight restructuring and com-
paction of the protein that does not involve any measurable
change of the secondary structure. It should be kept in mind,
however, that in structurally heterogeneous proteins, chem-
ical shifts and hydrodynamic NMR data represent averages
over the individual structures, so long as the dynamic inter-
conversion of the different conformers that are sampled by
the protein is fast on the NMR chemical shift timescale
(approximately milliseconds). Therefore, it is critical to
characterize the structural dynamics of Bet v 1.0101 in
more detail.NMR relaxation experiments
NMR spectroscopy provides various experimental tools for
characterizing the structural dynamics of proteins on various
timescales (47,48). The order parameter S2, which is acces-
sible from backbone amide relaxation experiments, is sensi-
tive to picosecond–nanosecond dynamics of backbone
amide NH groups (47). Fig. 4 compares the experimental
backbone NH order parameters of Bet v 1.0101 without
and with SDS bound. Extreme S2 values of 1 and 0 corre-
spond to fully restricted and unconstrained internal mobility
of the backbone amide NH group, respectively. S2 values >
0.7 are found for both protein states, which is characteristic
for well-ordered and folded proteins.
The order parameter S2 versus the residue profile (Fig. 4)
provides a strong indication as to which regions of the Bet v
1.0101 protein backbone become more ordered (on the pico-
second–nanosecond timescale) upon ligand binding. Inter-
estingly, with the exception of helix a3, the S2 values for
Bet v 1.0101 in complex with SDS are generally higher
than those for the apo protein, indicating that the backbone
of Bet v 1.0101 becomes more rigid upon complex forma-
tion. Rigidification is most prominent for the first strandof the central b-sheet (b1) and the short helices a1 and
a2, as well as for loops between secondary structure ele-
ments (e.g., b2/b3, b5/b6, and b7/a3). Notably, ligand bind-
ing does not affect the dynamics of the central part of the
b-sheet (b2b7) and the long helix a3 to a similar degree.
From the backbone amide relaxation data, we obtained
the rotational correlation time, tc, of Bet v 1.0101. We found
that ligand binding slightly accelerates rotational diffusion,
i.e., the value of tc for SDS-bound Bet v 1.0101 (tc¼ 8.4 ns)
is slightly smaller than that for the ligand-free protein (tc ¼
8.7 ns). The backbone amide relaxation data are thus consis-
tent with the translational diffusion data, with both indi-
cating a ligand-induced compaction of Bet v 1.
To further probe the structural dynamics of apoBet v 1.0101
in comparison with Bet v 1.0101 complexes, we perfor-
med 15N backbone amide relaxation dispersion experiments.
These experiments are sensitive to dynamic processes that
occur on themicrosecond–millisecond timescale, suchas tran-
sitions between different conformers in structural ensembles
(47,48). Fig. 5 shows representative 15N backbone amide
relaxation dispersion data for Bet v 1.0101 before and after
SDS, STS, and ANS binding.
It is evident from the nonflat relaxation dispersion profiles
in the apo protein that Bet v 1.0101 is dynamic on the micro-
second–millisecond timescale. Various amino acid residues
throughout the protein backbone are involved in this dy-
namic process, including the helix-loop-helix segment a1/
a2, the central b-sheet, and the C-terminal helix a3
(Fig. 5). A comparison with the relaxation dispersion data
for ligand-bound Bet v 1.0101 reveals a striking difference:
irrespective of the nature of the bound ligand (i.e., SDS,
STS, or ANS), all backbone amide resonances display flat
or almost flat relaxation dispersion profiles. This clearly
shows that ligand binding is accompanied by a significant
reduction of the conformational heterogeneity and rigidifi-
cation of the Bet v 1.0101 protein backbone.
The relaxation dispersion data contain structural informa-
tion in the form of chemical shift differences between the
conformers that are sampled by microsecond–millisecond
dynamic processes (47,48). We performed a quantitative
analysis by globally fitting the Carver-Richards equationFIGURE 4 Picosecond–nanosecond dynamics
of Bet v 1. Backbone amide 15N order parameters
S2 and error bars of apo (black) and SDS-bound
Bet v 1.0101 (blue) are shown as a function of res-
idue number. Averages of S2 (within a sliding win-
dow of 52 residues) are indicated by black and
blue lines, respectively. To see this figure in color,
go online.
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FIGURE 5 Millisecond timescale dynamics in
Bet v 1. (A–D) CPMG relaxation dispersion pro-
files for the 15N backbone amides of eight repre-
sentative residues, along with best-fit lines, of (A)
apo Bet v 1.0101, (B) SDS-bound Bet v 1.0101,
(C) STS-bound Bet v 1.0101, and (D) ANS-bound
Bet v 1.0101, recorded at 500 MHz (298 K).
2978 Grutsch et al.(30) to the experimental data, which revealed a common
exchange process (3.5 5 0.2 ms) in the intermediate
NMR exchange regime and enabled us to reliably determine
the chemical shifts. In apo Bet v 1.0101, the variation of the
backbone amide 15N chemical shifts between the con-
formers that are present in the structural ensemble are fairly
small (<1 ppm), suggesting that they differ only moderately
in their backbone conformation. Residues with significant
chemical differences between conformers cluster in the he-
lix-loop-helix segment a1/a2 (Ile-23, Leu-24, Gly-26, Asp-
27), in the central b-sheet (Ile-56, Arg-70, Val-74, Tyr-83,
Ile-86, Ile-103, Lys-115, and Ile-116), and in the C-terminal
helix a3 (Val-133, Lys-137, and Glu-141). It is noteworthy
that all chemical shift variations are well below the values
that are expected for unfolding of the protein or a loss of sec-
ondary structure (49,50). Interestingly, however, the chemi-
cal shift differences between conformers in the apo protein
are comparable to the chemical shift changes we observe for
ligand binding using HSQC titrations (Fig. 6). A plot of the
backbone amide 15N chemical shift differences between apo
Bet v 1.0101 and SDS-bound Bet v 1.0101 versus the relax-
ation-dispersion-derived chemical shift variations between
the conformers that are present in the apo protein reveals
a roughly linear correlation, with a correlation coefficient
of 0.87. This directly demonstrates that the conformational
space that is dynamically sampled by Bet v 1.0101 in the
absence of ligand already includes conformers that resemble
the ligand-bound protein.Biophysical Journal 107(12) 2972–2981DISCUSSION
Structural studies of PR-10 proteins with and without li-
gand(s) bound have indicated only a very limited variability
of the 3D structure (1,8,16). A comparison of the major
birch pollen allergen Bet v 1.0101 bound to naringenin,
kinetin, ANS, and DXC with the apo protein reveals only
minor differences between these structures, irrespective of
the exact nature and number of the bound ligand mole-
cule(s) (1,8). Our dynamic and hydrodynamic data for Bet
v 1.0101 point to a distinct difference between the ligand-
bound and ligand-free forms of this protein. Bet v 1.0101
displays a measurably higher degree of conformational dy-
namics on timescales ranging from picoseconds–nanosec-
onds to microseconds–milliseconds in its apo form than
when ligand is bound. Likewise, the hydrodynamic proper-
ties of these two forms of Bet v 1.0101 are notably different,
indicating that before ligand binding, the 3D structure of this
protein is less compact and has a larger average hydrody-
namic radius than it does after the ligand is bound to the
interior cavity. Taken together, our data suggest that ligand
binding to Bet v 1.0101 is accompanied by a defined rigid-
ification of the protein backbone along with a compaction of
the 3D structure.
In previous crystallographic studies, it was noted that Bet
v 1.0101 has three possible entry points for ligands into the
hydrophobic cavity (1,8). Evidently, however, neither of
these entry points is large enough to allow for the passage
FIGURE 6 Correlation of relaxation dispersion
and titration chemical shifts. Left: plot of the fitted
relaxation-dispersion-derived chemical shift differ-
ences (Dudisp) versus the measured
15N backbone
chemical shift differences between apo Bet v
1.0101 and SDS-bound Bet v 1.0101 (Dubind).
Right: 1H-15N-HSQC titration of Bet v 1.0101
with SDS. Spectra are shown for protein/ligand ra-
tios between 1:0 (orange) and 1:3 (black). To see
this figure in color, go online.
Dynamics and Compactness of Bet v 1 2979of voluminous ligand molecules. Therefore, local restructur-
ing of Bet v 1.0101 is a prerequisite for entry of ligand mol-
ecules into the binding cavity. It is conceivable that the
conformational heterogeneity we observe for apo Bet v
1.0101 is related to the mechanism by which this protein
binds ligand molecules. The conformational space that is
covered by the apo protein includes conformers that are
less compact and have a larger hydrodynamic radius than
when ligand is bound. Thus, entrance to the binding sites
in the inner hydrophobic pocket could occur predominantly
through these larger and more open conformers, where entry
of ligand molecules to the internal cavity is alleviated.
Ligand binding would then shift the populations of con-
formers that are present in apo Bet v 1 toward the more
compact (closed) ligand-bound state of the protein, which
is observed in crystal structures. Concomitantly, the confor-
mational heterogeneity of Bet v 1 would be reduced and a
more homogeneous structural ensemble would be observed
for the ligand-bound form of the protein.
Such a mechanism of ligand capture and binding is partic-
ularly supported by the NMR relaxation dispersion data,
which show that conformers that are very similar to the
ligand-bound form are already dynamically sampled in the
apo form of the protein, i.e., even without ligand being
available for binding. Moreover, these data also clearly
demonstrate that the level of conformational heterogeneity
in Bet v 1 is significantly reduced when ligand is bound, ir-
respective of the nature of the bound ligand. The rigidifica-
tion on the microsecond–millisecond timescale is paralleled
by a measurable rigidification on the picosecond–nano-
second timescale, as is evident from the NMR order
parameters.
It is instructive to analyze the structural details of the dy-
namic sampling that is present in Bet v 1.0101 before ligand
binding. The relaxation dispersion data imply that the milli-
second–microsecond structural variations in the apo protein
are relatively small, which excludes the disruption of sec-
ondary structure elements or unfolding processes. The lar-
gest dispersion profiles are found for amino acid residuesin the protein interior (the central b-sheet and the C-terminal
helix a3), i.e., close to the ligand-binding site, and in the
helix-loop-helix segment a1/a2. Our data suggest that
the millisecond–microsecond dynamic conformational sam-
pling in apo Bet v 1.0101 is most likely related to the confor-
mational selection mechanism by which this protein
captures and binds ligand molecules.
This finding is complemented by the observed pico-
second–nanosecond timescale dynamics. NMR order pa-
rameters show that in apo Bet v 1.0101, dynamics on this
timescale is most prominent for parts of the structure (the
b1-a1-a2 segment and loops) that connect the central b-
sheet to the long C-terminal helix a3. In Bet v 1 structures,
helices a1 and a2 are arranged in such way that they
embrace the C-terminus of helix a3 (Fig. 1). Together
with strand b1, this protein segment constitutes a significant
portion of the interaction surface between helix a3 and the
b-sheet. The N-terminus of helix a3 is connected to the cen-
tral b-sheet by the long loop between strand b7 and helix a3,
which is also more dynamic in the apo protein than in the
ligand-bound form. Thus, it appears that in apo Bet v
1.0101, the interactions between the long C-terminal helix
a3 and the remainder of the protein are mediated by rela-
tively dynamic structural segments. Ligand binding to the
protein interior is accompanied by a rigidification of the
interaction surface, which locks the helix into a more rigid
arrangement. Such a process could serve to define the posi-
tion of helix a3 with respect to the central b-sheet. We hy-
pothesize that the observed rigidification of the Bet v 1.0101
backbone results from stabilizing interactions at the inter-
face between bound ligand and protein.
In a recent study, it was shown that binding of DXC to Bet
v 1.0101 stabilizes the protein and increases resistance to
proteolysis (18). The thermodynamic stabilities of aller-
genic proteins are known to play a significant role in the pro-
teolytic processing of these molecules and subsequent
presentation of the fragments via the MHC class II complex
(51,52). It is tempting to speculate that for Bet v 1, the less
compact conformers that are transiently populated in theBiophysical Journal 107(12) 2972–2981
2980 Grutsch et al.apo protein display enhanced susceptibility to proteolytic
digestion by exposure of structurally buried amino acid res-
idues. Moreover, the conformational flexibility that we
observe for Bet v 1 could contribute to optimal positioning
of the epitope residues on the protein surface and facilitate
cross-linking of FcεRI receptors (53). Conformational plas-
ticity is often a prerequisite for efficient recognition of bio-
logical targets (54). Taken together, our results provide a
possible structural basis for the observed differences in the
immunogenic and allergenic properties of Bet v 1 (18).
In summary, we have shown that Bet v 1.0101 without li-
gand(s) bound displays significantly different dynamic and
hydrodynamic properties compared with the ligand-bound
protein. Our dynamic NMR data indicate that ligand capture
and binding occur by a mechanism for which millisecond–
microsecond timescale sampling of different conformers is
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